Evidence map›Paper›PMID 41403743›Full record

ReviewAdvanced pharmaceutical bulletin2025

The Role of Autophagy in Long-term Effects of Spinal Cord Injury: Does Exosome Change the Autophagy Process and Vice Versa?

Naeimeh Akbari-Gharalari, Abbas Ebrahimi-Kalan, Zeinab Aliyari-Serej, Hamid Soltani Zangbar, Maryam Ghahremani-Nasab, Yahya Yahyavi, Ayyub Ebrahimi, Negar Aghaei, Farshad Nezhadshahmohammad

Abstract readReview
In one paragraph

Review in Advanced pharmaceutical bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Naeimeh Akbari-GharalariNeurophysiology Research Center, Cellular and Molecular Medicine Research Institute, Urmia University of Medical Sciences, Urmia, Iran.ORCID https://orcid.org/0009-0007-3724-2061
Abbas Ebrahimi-KalanDepartment of Neuroscience and Cognition, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID https://orcid.org/0000-0001-5466-6754
Zeinab Aliyari-SerejDepartment of Applied Cell Sciences, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Hamid Soltani ZangbarDepartment of Neuroscience and Cognition, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Maryam Ghahremani-NasabStem Cells and Regenerative Medicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Yahya YahyaviDepartment of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Ayyub EbrahimiDepartment of Molecular Biology and Genetic, Faculty of Arts and Sciences, Halic University, Istanbul, Turkey.
Negar AghaeiFaculty of Medicine, Tabriz Medical Sciences, Islamic Azad University, Tabriz, Iran.
Farshad NezhadshahmohammadDepartment of Mining Engineering, Faculty of Engineering, Urmia University, Urmia, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review explores the synergistic effects of exosomes and autophagy in mitigating spinal cord injury (SCI) while elucidating the underlying molecular mechanisms. We evaluate current literature on the roles of exosomes and autophagy in SCI, highlighting key findings from both in vitro and in vivo studies. Previous research has demonstrated the contributions of these processes to cellular responses under SCI-related conditions. Additionally, animal models have provided insights into the therapeutic potential of modulating exosome and autophagy pathways. The overview discusses the activation of mTOR signaling and autophagy-related proteins, emphasizing their impacts on inflammation and axonal integrity. We identify a synergistic mechanism in which exosome-mediated cargo delivery and autophagy modulation work together to mitigate the effects of SCI. The regulation of the mTOR pathway and autophagy-related proteins is crucial for reducing inflammation and preserving axonal integrity. These findings underscore the therapeutic potential of targeting exosomes and autophagy for SCI treatment. The collaborative actions of these cellular processes present promising therapeutic avenues for SCI and possibly other neurological disorders. This review underscores the necessity for further studies to unravel the molecular intricacies and to translate these findings into clinical applications for SCI patients.

Indexed as

AutophagyExosomeSignaling pathwaysSpinal cord injury

Identifiers

PMID41403743
PMCPMC12703383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.